Lipoxygenase inhibitor, GSK2190915, Purity ≥98%

Cat. No.: X24-09-YM439

Lipoxygenase inhibitor, GSK2190915, Purity ≥98%

Synonym: 936350-00-4; GSK-2190915; GSK 2190915; AM-803; AM803; AM 803; Fiboflapon; 3-[3-Tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoic acid; Lipoxygenase inhibitor

  • CAS Number: 936350-00-4
  • Compound CID: 44473151
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
GSK2190915 is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting lipoxygenase. The molecular weight of the compound is 637.83, and its molecular formula is C38H43N3O4S. It targets the LTB4.
Molecular Weight
637.83
Molecular Formula
C38H43N3O4S
Targets
LTB4
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
GSK2190915 can be studied extensively for its potential therapeutic applications in the treatment of fibrotic diseases and cancers, where LPA signaling plays a significant role in promoting cell proliferation and migration.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0